ARTICLE | Company News
Cumbre Pharmaceuticals Inc., TB Alliance deal
October 2, 2006 7:00 AM UTC
The partners will design, synthesize and optimize Rif-nitroimidazole and quinolone-nitroimidazole antibiotics to treat tuberculosis. The alliance will have exclusive rights to products to treat TB and...